Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,731 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gene expression profiling of circulating tumor cells captured by MicroCavity Array is superior to enumeration in demonstrating therapy response in patients with newly diagnosed advanced and locally advanced non-small cell lung cancer.
Cohen EN, Jayachandran G, Gao H, Peabody P, McBride HB, Alvarez FD, Bravo PL, Qiao W, Liu S, Yao L, Lin SH, Reuben JM. Cohen EN, et al. Among authors: yao l. Transl Lung Cancer Res. 2023 Jan 31;12(1):109-126. doi: 10.21037/tlcr-22-314. Epub 2023 Jan 16. Transl Lung Cancer Res. 2023. PMID: 36762061 Free PMC article.
Phase I Trial of Definitive Concurrent Chemoradiotherapy and Trametinib for KRAS-Mutated Non-Small Cell Lung Cancer.
Lin SH, Lin HY, Verma V, Xu-Welliver M, Thall PF, Yao L, Kim PY, Gombos DS, Kawedia JD, Komaki R, Gomez DR, Nguyen QN, O'Reilly MS, Lu C, Fossella FV, Skoulidis F, Zhang J, Tsao AS, Heymach JV, Blumenschein GR. Lin SH, et al. Among authors: yao l. Cancer Treat Res Commun. 2022;30:100514. doi: 10.1016/j.ctarc.2022.100514. Epub 2022 Jan 7. Cancer Treat Res Commun. 2022. PMID: 35051703 Free PMC article.
Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial.
Liu Y, Yao L, Kalhor N, Carter BW, Altan M, Blumenschein G, Byers LA, Fossella F, Gibbons DL, Kurie JM, Lu C, Skoulidis F, Chang JY, Liao Z, Gomez DR, O'Reilly M, Heymach JV, Tsao AS, Lin SH. Liu Y, et al. Among authors: yao l. Lung Cancer. 2022 Dec;174:112-117. doi: 10.1016/j.lungcan.2022.10.006. Epub 2022 Oct 29. Lung Cancer. 2022. PMID: 36371941 Clinical Trial.
Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC.
Lin SH, Lin Y, Yao L, Kalhor N, Carter BW, Altan M, Blumenschein G, Byers LA, Fossella F, Gibbons DL, Kurie JM, Lu C, Simon G, Skoulidis F, Chang JY, Jeter MD, Liao Z, Gomez DR, O'Reilly M, Papadimitrakopoulou V, Thall P, Heymach JV, Tsao AS. Lin SH, et al. Among authors: yao l. J Thorac Oncol. 2020 Feb;15(2):248-257. doi: 10.1016/j.jtho.2019.10.024. Epub 2019 Nov 25. J Thorac Oncol. 2020. PMID: 31778797 Free article. Clinical Trial.
Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer.
Lin SH, Hobbs BP, Verma V, Tidwell RS, Smith GL, Lei X, Corsini EM, Mok I, Wei X, Yao L, Wang X, Komaki RU, Chang JY, Chun SG, Jeter MD, Swisher SG, Ajani JA, Blum-Murphy M, Vaporciyan AA, Mehran RJ, Koong AC, Gandhi SJ, Hofstetter WL, Hong TS, Delaney TF, Liao Z, Mohan R. Lin SH, et al. Among authors: yao l. J Clin Oncol. 2020 May 10;38(14):1569-1579. doi: 10.1200/JCO.19.02503. Epub 2020 Mar 11. J Clin Oncol. 2020. PMID: 32160096 Free PMC article. Clinical Trial.
Repeat Peroral Endoscopic Myotomy: Technical Difficulty and Risk Factors.
Ma LY, Guo KY, Liu ZQ, Chen SY, Zhong YS, Zhang YQ, Chen WF, Ma LL, Qin WZ, Hu JW, Cai MY, Yao LQ, Li QL, Zhou PH. Ma LY, et al. Among authors: yao lq. Gastrointest Endosc. 2024 Nov 16:S0016-5107(24)03729-5. doi: 10.1016/j.gie.2024.11.019. Online ahead of print. Gastrointest Endosc. 2024. PMID: 39557206
8,731 results